A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development
- 36 Downloads
In recent years, long noncoding RNAs (lncRNAs) have received increasing attention as important regulators of cancer development. As yet, however, a large fraction of them has not been characterized in detail, and the functional role of LINC00346 in hepatocellular carcinoma (HCC) has remained unclear.
The role of LINC00346 in HCC development was investigated using both in vitro and in vivo assays. Interactions between LINC00346, miR-542-3p and WDR18 were assessed using luciferase reporter, RT-qPCR and Western blotting assays. Loss- and gain-of-function experiments were performed to assess the roles of LINC00346, miR-542-3p and WDR18 in HCC cell viability, proliferation, migration and invasion.
We found that LINC00346 was upregulated in primary HCC tissues and HCC-derived cell lines and that LINC00346 may promote HCC cell viability, proliferation, migration and invasion. Furthermore, we found that LINC00346 may regulate WDR18 expression via competitively binding to miR-542-3p. This miRNA was found to be downregulated in primary HCC tissues and to act as a tumor suppressor that can inhibit HCC cell viability, proliferation, migration and invasion. In contrast, WDR18 was found to be upregulated in primary HCC tissues and to act as an oncogene. Additional functional studies indicated that WDR18 can activate the Wnt/β-catenin signaling pathway and its downstream effectors in HCC cells. We also found that LINC00346, through competitive sponging of miR-542-3p, may enhance the expression of WDR18 and activate the Wnt/β-catenin signaling pathway in HCC cells. Finally, a positive feedback loop involving LINC00346, β-catenin and MYC in HCC cells was uncovered.
Our results indicate an oncogenic role of LINC00346 in HCC cells via a positive feedback loop involving LINC00346, β-catenin and MYC, and they may be instrumental for the design of novel HCC biomarkers and/or therapeutic strategies.
KeywordsHepatocellular carcinoma LINC00346 miR-542-3p WDR18 Wnt/β-catenin signaling pathway
long non-coding RNA
Fetal bovine serum
Real-time quantitative PCR
Dulbecco’s Modified Eagle Medium
Roswell Park Memorial Institute
We thank the Second Affiliated Hospital of Nanchang University for providing the 90 paired HCC and adjacent normal liver tissues. This work was supported by the National Natural Science Foundation of China (No.81760427).
Compliance with ethical standards
Conflict of interest
- 5.D. Pulte, J. Weberpals, C.C. Schröder, K. Emrich, B. Holleczek, A. Katalinic, S. Luttmann, E. Sirri, L. Jansen, H. Brenner, Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century. Int J Cancer 143, 324–332 (2018)PubMedCrossRefGoogle Scholar
- 33.J. Yang, F. Han, W. Liu, H. Chen, X. Hao, X. Jiang, L. Yin, Y. Huang, J. Cao, H. Zhang, J. Liu, ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway. J Exp Clin Cancer Res 36, 170 (2017)PubMedPubMedCentralCrossRefGoogle Scholar
- 35.J. Sun, T. Zhang, M. Cheng, L. Hong, C. Zhang, M. Xie, P. Sun, R. Fan, Z. Wang, L. Wang, J. Zhong, TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/beta-catenin signaling pathway. J Exp Clin Cancer Res 38, 104 (2019)PubMedPubMedCentralCrossRefGoogle Scholar
- 47.T.P. Xu, P. Ma, W.Y. Wang, Y. Shuai, Y.F. Wang, T. Yu, R. Xia, Y.Q. Shu, KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. Cell Death Differ (2019). https://doi.org/10.1038/s41418-41018-40236-y
- 48.C. Wu, H.F. Zhang, N. Gupta, A. Alshareef, Q. Wang, Y.H. Huang, J.T. Lewis, D.N. Douglas, N.M. Kneteman, R. Lai, A positive feedback loop involving the Wnt/beta-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. J Hematol Oncol 9, 120 (2016)PubMedPubMedCentralCrossRefGoogle Scholar
- 58.P. Han, J.-W. Li, B.-M. Zhang, J.-C. Lv, Y.-M. Li, X.-Y. Gu, Z.-W. Yu, Y.-H. Jia, X.-F. Bai, L. Li, Y.-L. Liu, B.-B. Cui, The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer 16, 9 (2017)PubMedPubMedCentralCrossRefGoogle Scholar